NCT02947126View on ClinicalTrials.gov

Multilevel Models of Therapeutic Response in the Lungs

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

February 29, 2020

Study Completion Date

December 31, 2022

Conditions
Cystic Fibrosis
Interventions
DRUG

Hypertonic Saline

Inhaled 7% Hypertonic saline

DRUG

Isotonic Saline

Inhaled 0.9% Isotonic saline

DRUG

Indium-DTPA

Inhaled Indium 111 DTPA

DRUG

Technetium Sulfur Colloid

Inhaled Technetium99m sulfur colloid

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Tim Corcoran

OTHER

NCT02947126 - Multilevel Models of Therapeutic Response in the Lungs | Biotech Hunter | Biotech Hunter